Published in J Clin Oncol on October 10, 2006
A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care | NCT02831439
Bending the cost curve in cancer care. N Engl J Med (2011) 5.02
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol (2010) 2.94
Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med (2009) 2.70
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med (2009) 2.36
Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol (2013) 2.32
The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr (2010) 2.25
Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer (2007) 2.07
Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology (2012) 2.07
Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med (2013) 2.00
Surgical mammography reporting in a limited resource environment. World J Surg (2010) 1.93
Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract (2010) 1.85
Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med (2014) 1.85
Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med (2007) 1.65
High-cost imaging in elderly patients with stage IV cancer. J Natl Cancer Inst (2012) 1.63
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V. J Clin Oncol (2016) 1.54
Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer (2007) 1.36
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat (2010) 1.29
Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer. J Clin Oncol (2010) 1.25
Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer. Oncologist (2012) 1.18
Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. Cancer Prev Res (Phila) (2013) 1.17
Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer (2007) 1.17
Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA (2011) 1.15
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. Geburtshilfe Frauenheilkd (2013) 1.14
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat (2010) 1.11
Caring for survivors of breast cancer: perspective of the primary care physician. Curr Oncol (2011) 1.11
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer. Int J Clin Oncol (2011) 1.11
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer. Int J Cancer (2009) 1.08
Breast Cancer: State of the Art and New Findings. Geburtshilfe Frauenheilkd (2012) 1.01
Assessment of clinical practices among cancer genetic counselors. Fam Cancer (2010) 1.01
NHERF1/EBP50 in Breast Cancer: Clinical Perspectives. Breast Care (Basel) (2010) 1.00
Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer. J Clin Oncol (2011) 0.98
Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer (2012) 0.97
Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns. J Oncol Pract (2011) 0.97
Early breast cancer in the older woman. Oncologist (2011) 0.97
Impact of survivorship-based research on defining clinical care guidelines. Cancer Epidemiol Biomarkers Prev (2011) 0.97
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection. BMC Cancer (2009) 0.96
Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer (2013) 0.96
Second malignancies among elderly survivors of cancer. Oncologist (2011) 0.95
FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis. J Cancer Res Clin Oncol (2010) 0.95
Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol (2013) 0.95
Future directions for the early detection of recurrent breast cancer. J Cancer (2014) 0.95
Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol (2009) 0.92
Surveillance mammography for Medicaid/Medicare breast cancer patients. J Cancer Surviv (2009) 0.91
It takes a team: CanIMPACT: Canadian Team to Improve Community-Based Cancer Care along the Continuum. Can Fam Physician (2016) 0.90
Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling. BMC Biochem (2007) 0.90
Usefulness of (18)F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases. Nucl Med Mol Imaging (2012) 0.90
Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev (2013) 0.90
Survivorship services for adult cancer populations: a pan-Canadian guideline. Curr Oncol (2011) 0.89
Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer (2014) 0.89
Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment. Health Qual Life Outcomes (2009) 0.88
Proposed follow up programme after curative resection for lower third oesophageal cancer. World J Surg Oncol (2010) 0.87
Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804. Cancer (2009) 0.87
The impact of primary care physicians on follow-up care of underserved breast cancer survivors. J Am Board Fam Med (2013) 0.87
Comparison of international breast cancer guidelines: are we globally consistent? cancer guideline AGREEment. Curr Oncol (2012) 0.86
Physicians' beliefs about breast cancer surveillance testing are consistent with test overuse. Med Care (2013) 0.86
Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv (2013) 0.86
Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain. BMC Cancer (2010) 0.86
Prospective study of factors predicting adherence to surveillance mammography in women treated for breast cancer. J Clin Oncol (2012) 0.85
Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer. Breast Cancer Res Treat (2013) 0.85
Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol (2016) 0.85
Options for early breast cancer follow-up in primary and secondary care - a systematic review. BMC Cancer (2012) 0.84
Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case for. Breast Cancer Res (2008) 0.83
Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women. J Cancer Surviv (2013) 0.83
Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press) (2011) 0.83
Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance. Semin Oncol (2013) 0.82
Breast cancer survivorship issues. Hematol Oncol Clin North Am (2013) 0.82
Effect of HER2 status on distant recurrence in early stage breast cancer. Breast Cancer Res Treat (2012) 0.82
The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status. Cancer Causes Control (2012) 0.82
An intervention to improve communication between breast cancer survivors and their physicians. J Psychosoc Oncol (2010) 0.82
Therapeutic mammaplasty for breast cancer: oncological and aesthetic outcomes. World J Surg (2013) 0.82
A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors. Breast Cancer Res Treat (2012) 0.81
'Omic approaches to preventing or managing metastatic breast cancer. Breast Cancer Res (2011) 0.81
Different annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer surveillance after breast-conserving surgery. Oncologist (2011) 0.81
Quality of cancer follow-up care: a focus on Latina breast cancer survivors. J Cancer Surviv (2014) 0.81
Endocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors. J Cancer Surviv (2014) 0.81
Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia. Curr Oncol (2014) 0.80
Surveillance mammography among female Department of Defense beneficiaries: a study by race and ethnicity. Cancer (2013) 0.80
Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers. J Eval Clin Pract (2016) 0.80
Use of annual mammography among older women with ductal carcinoma in situ. J Gen Intern Med (2011) 0.79
Follow-up care for breast cancer survivors: improving patient outcomes. Patient Relat Outcome Meas (2014) 0.79
Mandibular Metastasis of a Signet Ring Cell Carcinoma of the Breast in a Patient who Underwent Bilateral Mastectomy more than 25 Years Earlier. Breast Care (Basel) (2009) 0.79
An analysis of the association between cancer-related information seeking and adherence to breast cancer surveillance procedures. Cancer Epidemiol Biomarkers Prev (2012) 0.79
Evaluating surveillance breast imaging and biopsy in older breast cancer survivors. Int J Breast Cancer (2012) 0.79
Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer (2011) 0.78
The reality in the surveillance of breast cancer survivors-results of a patient survey. Breast Cancer (Auckl) (2008) 0.78
Exometabolom analysis of breast cancer cell lines: Metabolic signature. Sci Rep (2015) 0.78
Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case against. Breast Cancer Res (2008) 0.78
Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes? BMC Health Serv Res (2011) 0.78
Chest X-ray in the follow-up of renal cell carcinoma. World J Urol (2013) 0.77
Patterns of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting in China. Chin J Cancer Res (2016) 0.77
Patient surveillance after initial breast cancer therapy: variation by physician specialty. Am J Surg (2013) 0.77
Models of care for early-stage breast cancer in Canada. Curr Oncol (2011) 0.77
Survivorship care plans and time since diagnosis: factors that contribute to who breast cancer survivors see for the majority of their care. Support Care Cancer (2015) 0.77
Current approaches to the management of Her2-negative metastatic breast cancer. Breast Cancer Res (2012) 0.77
First indicators of relapse in breast cancer: evaluation of the follow-up program at our hospital. Int J Clin Oncol (2012) 0.77
Quality of post-treatment surveillance of early stage breast cancer in Texas. Surgery (2013) 0.76
Breast Cancer Risks and Effectiveness of BSE Training among Women Living in a District of İstanbul. J Breast Health (2013) (2014) 0.75
The effect of surveillance on the outcome of breast cancer patients. Iran J Cancer Prev (2013) 0.75
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med (2005) 33.60
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol (2006) 25.12
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med (2007) 20.19
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol (2010) 14.41
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol (2007) 14.29
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med (2003) 13.81
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol (2013) 12.57
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol (2006) 11.26
American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol (2006) 11.07
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol (2003) 9.72
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol (2009) 9.39
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol (2005) 8.56
Estrogen carcinogenesis in breast cancer. N Engl J Med (2006) 8.17
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol (2006) 7.43
Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2011) 7.24
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol (2012) 7.16
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol (2004) 7.16
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol (2003) 6.66
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol (2004) 6.59
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol (2013) 6.56
Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med (2008) 6.54
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA (2006) 6.45
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol (2010) 6.39
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol (2008) 6.31
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol (2003) 5.69
Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med (2009) 5.68
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol (2014) 5.61
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst (2005) 5.55
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol (2007) 5.36
Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med (2014) 5.18
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med (2010) 5.17
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol (2008) 5.10
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol (2006) 4.97
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol (2009) 4.95
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol (2010) 4.93
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med (2004) 4.84
Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31. J Clin Oncol (2011) 4.81
American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol (2011) 4.64
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial. J Clin Oncol (2006) 4.55
Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc (2005) 4.48
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA (2008) 4.48
American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays. J Clin Oncol (2004) 4.48
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol (2007) 4.45
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol (2008) 4.42
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2012) 4.42
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med (2010) 4.38
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol (2008) 4.29
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2005) 4.10
Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem (2009) 4.05
Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 3.92
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol (2007) 3.85
American Society Of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. J Clin Oncol (2009) 3.73
Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology (2008) 3.71
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol (2003) 3.71
Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol (2006) 3.71
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol (2009) 3.70
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res (2008) 3.67
Early specialty palliative care--translating data in oncology into practice. N Engl J Med (2013) 3.58
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol (2009) 3.51
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. J Clin Oncol (2008) 3.40
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. J Natl Cancer Inst (2002) 3.34